Skip to main content
Erschienen in: Journal of Genetic Counseling 3/2017

19.01.2017 | Original Research

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts

verfasst von: Hong Truong, Sarah E. Hegarty, Leonard G. Gomella, William K. Kelly, Edouard J. Trabulsi, Costas D. Lallas, Veda N. Giri

Erschienen in: Journal of Genetic Counseling | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Patients with suspected hereditary renal cell cancer (RCC) are under-referred for genetic evaluation. Characterizing the prevalence and characteristics of suspected inherited RCC is a crucial step toward advancing personalized, genetically-based cancer risk management for patients and their families. To evaluate the prevalence and characteristics of suspected inherited RCC syndromes based on consensus criteria, we performed a cross-sectional analysis of patients with a diagnosis of RCC in SEER (2001–2011, n = 105,754) and in our institutional cancer registry (2004–2013, n = 998). Consensus criteria for referral of patients with RCC for genetic evaluation from the American College of Medical Genetics and Genomics and National Society of Genetic Counselors (ACMG/NSGC) were applied to the two cohorts. The associations between meeting referral criteria with demographic characteristics were assessed with chi-square tests. Overall, 24.0 % of the SEER cohort and 33.7 % of our institutional cohort met ACMG/NSGC referral criteria for genetic counseling. While white patients more commonly met early onset clear cell RCC criteria, black patients met papillary RCC criteria at twice the rate of whites in both cohorts (p < 0.0001). As many as 1 in 5 individuals with RCC meet referral criteria for genetic evaluation based on newly emerging guidelines, with differences in pathology noted by race. Prospective genetic testing studies utilizing emerging referral guidelines should help to refine the genetic spectrum of inherited kidney cancer. This study supports efforts to increase awareness of referral of patients with RCC for genetic counseling particularly among urologic providers.
Literatur
Zurück zum Zitat Benusiglio, P. R., Giraud, S., Deveaux, S., Méjean, A., Correas, J.-M., Joly, D., et al. (2014). Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet Journal of Rare Diseases, 9(1), 163. doi:10.1186/s13023-014-0163-z.CrossRefPubMedPubMedCentral Benusiglio, P. R., Giraud, S., Deveaux, S., Méjean, A., Correas, J.-M., Joly, D., et al. (2014). Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet Journal of Rare Diseases, 9(1), 163. doi:10.​1186/​s13023-014-0163-z.CrossRefPubMedPubMedCentral
Zurück zum Zitat Chow, W. H., Shuch, B., Linehan, W. M., & Devesa, S. S. (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer. doi:10.1002/cncr.27690/full. Chow, W. H., Shuch, B., Linehan, W. M., & Devesa, S. S. (2013). Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer. doi:10.​1002/​cncr.​27690/​full.
Zurück zum Zitat Choyke, P. L., Glenn, G. M., Walther, M. M., Patronas, N. J., Linehan, W. M., & Zbar, B. (1995). Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology, 194(3), 629–642.CrossRefPubMed Choyke, P. L., Glenn, G. M., Walther, M. M., Patronas, N. J., Linehan, W. M., & Zbar, B. (1995). Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology, 194(3), 629–642.CrossRefPubMed
Zurück zum Zitat Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. Journal International Du Cancer, 136(5), E359–E386. doi:10.1002/ijc.29210 Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. Journal International Du Cancer, 136(5), E359–E386. doi:10.​1002/​ijc.​29210
Zurück zum Zitat Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., Wiesner, G. L., Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. (2015, January). A practice guideline from the American College of Medical Genetics and Genomics and the National Society of genetic counselors: referral indications for cancer predisposition assessment. Genetics in Medicine: Official Journal of the American College of Medical Genetics. doi:10.1038/gim.2014.147 Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., Wiesner, G. L., Guideline Development Group, American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and National Society of Genetic Counselors Practice Guidelines Committee. (2015, January). A practice guideline from the American College of Medical Genetics and Genomics and the National Society of genetic counselors: referral indications for cancer predisposition assessment. Genetics in Medicine: Official Journal of the American College of Medical Genetics. doi:10.​1038/​gim.​2014.​147
Zurück zum Zitat Howlader, N., Noone, A. M., Krapcho, M., & Garshell, J. (2013). SEER cancer statistics review, 1975–2010. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Bethesda (MD). Howlader, N., Noone, A. M., Krapcho, M., & Garshell, J. (2013). SEER cancer statistics review, 1975–2010. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Bethesda (MD).
Zurück zum Zitat Kara, O., Andrade, H. S., Zargar, H., Akca, O., Maurice, M. J., Caputo, P. A., et al. (2016). Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center. J Robotic Surgery. doi:10.1007/s11701-016-0562-3.PubMed Kara, O., Andrade, H. S., Zargar, H., Akca, O., Maurice, M. J., Caputo, P. A., et al. (2016). Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center. J Robotic Surgery. doi:10.​1007/​s11701-016-0562-3.PubMed
Zurück zum Zitat Kiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., et al. (2001). Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. The American Journal of Pathology, 159(3), 825–829. doi:10.1016/S0002-9440(10)61757-9.CrossRefPubMedPubMedCentral Kiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., et al. (2001). Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. The American Journal of Pathology, 159(3), 825–829. doi:10.​1016/​S0002-9440(10)61757-9.CrossRefPubMedPubMedCentral
Zurück zum Zitat Lehtonen, H. J. (2011). Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Familial Cancer, 10(2), 397–411.CrossRefPubMed Lehtonen, H. J. (2011). Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Familial Cancer, 10(2), 397–411.CrossRefPubMed
Zurück zum Zitat Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010). The genetic basis of kidney cancer: a metabolic disease. Nature Reviews Urology. Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010). The genetic basis of kidney cancer: a metabolic disease. Nature Reviews Urology.
Zurück zum Zitat Lonser, R. R., Glenn, G. M., Walther, M. C., & Chew, E. Y. (2003). von Hippel-Lindau disease. The Lancet, 361(9374), 2059–2067.CrossRef Lonser, R. R., Glenn, G. M., Walther, M. C., & Chew, E. Y. (2003). von Hippel-Lindau disease. The Lancet, 361(9374), 2059–2067.CrossRef
Zurück zum Zitat Patel, N. H., Attwood, K. M., Hanzly, M., Creighton, T. T., Mehedint, D. C., Schwaab, T., & Kauffman, E. C. (2015). Comparative analysis of smoking as a risk factor among renal cell carcinoma histological subtypes. The Journal of Urology, 194(3), 640–646. doi:10.1016/j.juro.2015.03.125.CrossRefPubMed Patel, N. H., Attwood, K. M., Hanzly, M., Creighton, T. T., Mehedint, D. C., Schwaab, T., & Kauffman, E. C. (2015). Comparative analysis of smoking as a risk factor among renal cell carcinoma histological subtypes. The Journal of Urology, 194(3), 640–646. doi:10.​1016/​j.​juro.​2015.​03.​125.CrossRefPubMed
Zurück zum Zitat Pavlovich, C. P., Walther, M. M., Eyler, R. A., Hewitt, S. M., Zbar, B., Linehan, W. M., & Merino, M. J. (2002). Renal tumors in the Birt-Hogg-Dubé syndrome. The American Journal of Surgical Pathology, 26(12), 1542–1552.CrossRefPubMed Pavlovich, C. P., Walther, M. M., Eyler, R. A., Hewitt, S. M., Zbar, B., Linehan, W. M., & Merino, M. J. (2002). Renal tumors in the Birt-Hogg-Dubé syndrome. The American Journal of Surgical Pathology, 26(12), 1542–1552.CrossRefPubMed
Zurück zum Zitat Reaume, M. N., Graham, G. E., Tomiak, E., Kamel-Reid, S., Jewett, M. A. S., Bjarnason, G. A., et al. (2013). Canadian guideline on genetic screening for hereditary renal cell cancers. Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada, 7(9–10), 319–323. doi:10.5489/cuaj.1496.CrossRefPubMedPubMedCentral Reaume, M. N., Graham, G. E., Tomiak, E., Kamel-Reid, S., Jewett, M. A. S., Bjarnason, G. A., et al. (2013). Canadian guideline on genetic screening for hereditary renal cell cancers. Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada, 7(9–10), 319–323. doi:10.​5489/​cuaj.​1496.CrossRefPubMedPubMedCentral
Zurück zum Zitat Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: a Cancer Journal for Clinicians, 65(1), 5–29. doi:10.3322/caac.21254. Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: a Cancer Journal for Clinicians, 65(1), 5–29. doi:10.​3322/​caac.​21254.
Zurück zum Zitat Störkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., et al. (1997). Classification of renal cell carcinoma: workgroup no. 1. Union Internationale Contre le cancer (UICC) and the American joint committee on cancer (AJCC). Cancer, 80(5), 987–989.CrossRefPubMed Störkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., et al. (1997). Classification of renal cell carcinoma: workgroup no. 1. Union Internationale Contre le cancer (UICC) and the American joint committee on cancer (AJCC). Cancer, 80(5), 987–989.CrossRefPubMed
Zurück zum Zitat Toro, J. R., Wei, M. H., Glenn, G. M., Weinreich, M., Toure, O., Vocke, C., et al. (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. Journal of Medical Genetics, 45(6), 321–331. doi:10.1136/jmg.2007.054304.CrossRefPubMedPubMedCentral Toro, J. R., Wei, M. H., Glenn, G. M., Weinreich, M., Toure, O., Vocke, C., et al. (2008). BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. Journal of Medical Genetics, 45(6), 321–331. doi:10.​1136/​jmg.​2007.​054304.CrossRefPubMedPubMedCentral
Zurück zum Zitat Wei, M. H., Toure, O., Glenn, G. M., Pithukpakorn, M., Neckers, L., Stolle, C., et al. (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. Journal of Medical Genetics, 43(1), 18–27. doi:10.1136/jmg.2005.033506.CrossRefPubMed Wei, M. H., Toure, O., Glenn, G. M., Pithukpakorn, M., Neckers, L., Stolle, C., et al. (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. Journal of Medical Genetics, 43(1), 18–27. doi:10.​1136/​jmg.​2005.​033506.CrossRefPubMed
Metadaten
Titel
Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
verfasst von
Hong Truong
Sarah E. Hegarty
Leonard G. Gomella
William K. Kelly
Edouard J. Trabulsi
Costas D. Lallas
Veda N. Giri
Publikationsdatum
19.01.2017
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 3/2017
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-016-0020-4

Weitere Artikel der Ausgabe 3/2017

Journal of Genetic Counseling 3/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.